Latest 8-K filings

Warner Music Group announced preliminary Q2 2026 results showing significant revenue and operating income increases, driven by strong performance in Recorded Music and Music Publishing.

Supernus Pharmaceuticals and Indivior Pharmaceuticals announced a merger of equals to create a diversified CNS biopharmaceutical leader with significant scale and projected annual cost synergies of at least $125 million.

Indivior and Supernus Pharmaceuticals announced a merger of equals to create a diversified CNS biopharmaceutical leader with significant scale and an expanded portfolio of 11 medicines.

Charter Communications announces the acquisition of key commercial fiber and managed IT/cloud services businesses from Cox Communications, along with residential cable assets, in a significant strategic move.

QHSLab, Inc. announced robust second quarter and first half 2026 financial results, highlighted by an over 86% increase in Integrated Service Program (ISP) revenue and expanding gross margins.

Freedom Metals Acquisition Corp. announced that its Class A ordinary shares and warrants will begin trading separately on August 4, 2026, offering investors more trading flexibility.

Beacon Financial Corporation announced the retirement of its General Counsel and Corporate Secretary, Wm. Gordon Prescott, and the appointment of John B. Eagan to the role, effective August 1, 2026, alongside the adoption of a new 'Good Leaver' policy for equity awards.

Innovate Corp. has entered into supplemental indentures to modify interest payment terms on its senior secured notes, allowing for payment-in-kind interest and extending a promissory note maturity.

Anavex Life Sciences announced plans to refresh its Board of Directors by nominating two new independent directors and urged stockholders to reject a control attempt by PVG Asset Management Corporation and Patrick S. Adams.

Douglas Dynamics announced record second quarter 2026 results, with net sales up 10% and adjusted diluted EPS up 7%, leading to an increased full-year outlook.

Avidbank Holdings, Inc. announced the appointment of Jonathan M. Dale as President of the Company and its subsidiary, Avidbank, effective August 3, 2026.

Petco Health and Wellness Company, Inc. announced the appointment of Jeffrey Naylor, former CFO of The TJX Companies, to its Board of Directors and as Chair of the Audit Committee, effective August 1, 2026.

Autolus Therapeutics plc announced a significant increase in its 2026 revenue guidance for AUCATZYL and secured a substantial credit facility, extending its cash runway into Q2 2028.

Cohen & Company Inc. announced robust second quarter 2026 financial results, driven by strong investment banking and trading revenues, leading to a significant increase in net income and the declaration of a quarterly dividend.

Design Therapeutics announced its second quarter 2026 financial results, highlighting progress in its RESTORE-FA trial for Friedreich's ataxia and initiation of a Phase 1 trial for DT-818 in myotonic dystrophy type 1, while also noting a delay in its FECD program.

Bowhead Specialty Holdings Inc. has entered into a definitive agreement to be acquired by American Family Mutual Insurance Company, S.I. for $34.00 per share in cash, valuing the company at approximately $1.2 billion.

W.W. Grainger, Inc. announced the resignation of its Senior Vice President and Chief Financial Officer, Deidra C. Merriwether, effective September 4, 2026, and the appointment of Laurie R. Thomson as interim CFO.

AGCO Corporation announces executive leadership transitions, appointing Indira Agarwal as CFO and Damon Audia to lead PTx & Corporate Strategy.

News Corporation has provided an update on its ongoing stock repurchase program, detailing recent buyback activity for its Class A and Class B common stock.

Edible Garden AG Incorporated announced an expanded multi-year private label supply agreement with a major Midwest big-box retailer, extending their partnership through December 31, 2028.

Hess Midstream LP announced its estimated results for the second quarter of 2026, reporting net income of $173.7 million and reaffirming full-year guidance.

Strategy Inc. reported on August 3, 2026, updates regarding its at-the-market offering, bitcoin sales and holdings, and share repurchase programs, alongside dividend declarations.

Strive, Inc. announced the purchase of 20 bitcoin and provided an update on its cash, digital asset, and stock holdings as of July 31, 2026.

Brookfield Asset Management has finalized its acquisition of Oaktree, consolidating its credit platform and expanding its global reach.

Lindblad Expeditions Holdings announced robust second-quarter 2026 financial results, showcasing a 19% revenue increase to $199.2 million and a significant improvement in net loss.

Rocket Pharmaceuticals announced a positive clinical safety update for its RP-A501 gene therapy in Danon disease, with initial patients showing good tolerance and no major adverse events.

Tyson Foods announced third quarter 2026 results, showcasing strength in its Chicken and Prepared Foods segments, with sales flat year-over-year and adjusted operating income up 8%.

Twist Bioscience announced record revenue of $118.4 million for its fiscal third quarter of 2026, a 23% increase year-over-year, and raised its full-year revenue guidance.

Cocrystal Pharma announced a $5 million private placement with existing investor OPKO Health, Inc., to advance its antiviral drug candidate programs.

Sally Beauty Holdings announced third quarter fiscal 2026 results, showing a slight increase in net sales and flat comparable sales, alongside significant growth in GAAP and Adjusted Diluted EPS.